Literature DB >> 28868286

Clinical and Spectral-Domain Optical Coherence Tomography Appearance of Optic Disc Melanocytoma: A New Classification and Differentiation from Pigmented Choroidal Lesions.

Supanut Apinyawasisuk1, Tara McCannel2, Anthony C Arnold2.   

Abstract

AIMS: The aim of this paper was to compare the features of both the classic, darkly pigmented and the atypical, more lightly pigmented optic disc melanocytoma with those of pigmented choroidal lesions.
METHODS: We analyzed the spectral-domain optical coherence tomography (SD-OCT) features of 9 eyes with optic disc melanocytoma and compared them with those of choroidal melanoma and nevus. RESULTS AND
CONCLUSION: We identified 2 categories of SD-OCT findings in optic disc melanocytoma: (a) type 1, the typical, prominent, hyperpigmented lesion with SD-OCT findings of a hyperreflective, disorganized overlying retina and a posterior hyporeflective shadow, and (b) the less common, atypical, minimally pigmented type 2 lesion overlaid by a relatively well-organized retina that lacks a posterior hyporeflective shadow. Choroidal lesions were characterized by tumor confined beneath the clearly visible hyperreflective line of the photoreceptor and retinal pigment epithelium, with minimal disorganization of the overlying retina.

Entities:  

Keywords:  Choroidal lesions; Optic disc melanocytoma; Spectral-domain optical coherence tomography

Year:  2016        PMID: 28868286      PMCID: PMC5566758          DOI: 10.1159/000453110

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  18 in total

1.  Optical coherence tomography study of optic disc melanocytoma.

Authors:  Rajat Chaudhary; Ritu Arora; Dinesh Kumar Mehta; Manisha Singh
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2006 Jan-Feb

2.  Documentation of optic disc melanocytoma by spectral and time domain optical coherence tomography.

Authors:  Vinay A Shah; Ryan D Vincent; Komal Desai; Gary Gallimore; Mahendra Rupani
Journal:  Can J Ophthalmol       Date:  2009-10       Impact factor: 1.882

3.  Three-dimensional spectral-domain optical coherence tomography of melanocytoma of the optic nerve head.

Authors:  Sandeep Saxena; Bhumika Sharma; Shashi K Bhasker
Journal:  J Ocul Biol Dis Infor       Date:  2011-08-10

4.  Melanocytoma of the Optic Nerve Head, Thirty-Month Follow-Up.

Authors:  Hasan Eldaly; Zeiad Eldaly
Journal:  Semin Ophthalmol       Date:  2014-02-07       Impact factor: 1.975

5.  Autofluorescence and spectral-domain optical coherence tomography of optic disk melanocytoma.

Authors:  Ricardo Luz Leitão Guerra; Eduardo Ferrari Marback; Igor Sandes Pessoa da Silva; Otacílio de Oliveira Maia Junior; Roberto Lorens Marback
Journal:  Arq Bras Oftalmol       Date:  2014 Nov-Dec       Impact factor: 0.872

Review 6.  Melanocytoma of the optic disk: a review.

Authors:  Jerry A Shields; Hakan Demirci; Arman Mashayekhi; Ralph C Eagle; Carol L Shields
Journal:  Surv Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 6.048

7.  Optical coherence tomography of optic disk melanocytoma in 15 cases.

Authors:  Carol L Shields; Benjamin Perez; Raquel Benavides; Miguel A Materin; Jerry A Shields
Journal:  Retina       Date:  2008-03       Impact factor: 4.256

8.  Hyperreflective dots surrounding the central retinal artery and vein in optic disc melanocytoma revealed by spectral domain optical coherence tomography.

Authors:  Akiko Okubo; Kazuhiko Unoki; Hiroshi Yoshikawa; Tatsuro Ishibashi; Munefumi Sameshima; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2012-11-09       Impact factor: 2.447

9.  Melanocytoma of the optic nerve head - a diagnostic dilemma.

Authors:  Zalilawati Mohmad; Tan Aik Kah; Ku Chui Yong; Wan Haslina Wan Abdul Halim; Then Kong Yong
Journal:  Clin Pract       Date:  2011-07-01

10.  Optical Coherence Tomography: An Adjunctive Tool for Differentiating between Choroidal Melanoma and Metastasis.

Authors:  Vicktoria Vishnevskia-Dai; Dinah Zur; Shiran Yaacobi; Iris Moroz; Hadas Newman; Meira Neudorfer
Journal:  J Ophthalmol       Date:  2016-02-22       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.